INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2013
Total net assets |
£176.0m |
NAV per share |
319.5p |
Share price |
302.0p |
Total value of unquoted investments |
£24.7m |
Total number of portfolio companies |
71 |
Top Ten Holdings
Company Name |
% NAV |
Gilead |
8.9 |
Celgene |
8.4 |
Amgen |
6.9 |
Regeneron |
6.5 |
Biogen |
6.0 |
Incyte |
4.4 |
NPS |
3.9 |
Alexion |
3.7 |
Aegerion |
3.3 |
Pharmacyclics |
3.2 |
|
----------- |
Total |
55.2 |
Trust Characteristics |
% NAV |
Profitable |
56 |
Becoming Profitable |
14 |
Unprofitable |
30 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
93 |
Europe |
7 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% NAV |
Quoted |
87 |
Unquoted |
13 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
15 NOVEMBER 2013